Laparoscopic myomectomy using the argon beam coagulator

Area of Science:

• Minimally Invasive Surgery
• Gynecologic Oncology
• Surgical Technology

Background:

• Uterine fibroids are common benign tumors affecting women of reproductive age.
• Symptomatic fibroids can cause significant morbidity, including heavy bleeding and pain.
• Laparoscopic myomectomy is a preferred surgical approach for fibroid removal.

Purpose of the Study:

• To evaluate the safety and efficacy of the argon beam coagulator (ABC) for laparoscopic myomectomy.
• To assess the hemostatic capabilities and visualization provided by the ABC during fibroid dissection.
• To determine the intraoperative outcomes in patients undergoing laparoscopic myomectomy with ABC.

Main Methods:

• Fourteen patients with symptomatic uterine fibroids underwent laparoscopic myomectomy.
• The argon beam coagulator (ABC) was utilized for myoma dissection in a non-touch technique.
• Fibroid size ranged from 2 cm to 6 cm; multiple fibroids were removed in eight patients.

Main Results:

• The argon beam coagulator (ABC) facilitated hemostatic dissection of uterine fibroids.
• Excellent surgical visualization was achieved due to minimal smoke production.
• No intraoperative complications were reported, with minimal operative blood loss observed.

Conclusions:

• The argon beam coagulator (ABC) is a safe and effective tool for laparoscopic removal of symptomatic uterine fibroids.
• The non-touch technique with ABC offers hemostasis and clear visualization, enhancing surgical outcomes.
• Laparoscopic myomectomy using ABC represents a viable option for managing uterine fibroids.